Showing results (451-460 of 472) with videos related to

Sort By:
Pageof 48
Plos Pathogens|July 5, 2022
Exposure modality influences viral kinetics but not respiratory outcome of COVID-19 in multiple nonhuman primate speciesAlyssa C Fears, Brandon J Beddingfield, Nicole R Chirichella, et al.
American Journal of Human Genetics|August 8, 2024
SMAD4 mutations causing Myhre syndrome are under positive selection in the male germlineKatherine A Wood, R Spencer Tong, Marialetizia Motta, et al.
Microorganisms|April 3, 2021
Space-Time Trends in Lassa Fever in Sierra Leone by ELISA Serostatus, 2012-2019Jeffrey G Shaffer, John S Schieffelin, Mambu Momoh, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Novel Tools for Lassa Virus Surveillance in Peri-domestic RodentsAllison R Smither, James Koninga, Franklyn B Kanneh, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of MK-1220: A Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma ExposureMichael T Rudd, John A McCauley, John W Butcher, et al.
The Lancet. Microbe|April 20, 2026
Evaluation of antigen and antibody assays for surveillance of Lassa virus in peri-domestic rodents in southeastern Sierra Leone: a cross-sectional studyAllison R Smither, James Koninga, Franklyn B Kanneh, et al.
Journal of Medicinal Chemistry|February 19, 2010
Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitorJohn A McCauley, Charles J McIntyre, Michael T Rudd, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 26, 2018
Pleiotropic Impacts of Macrophage and Microglial Deficiency on Development in Rats with Targeted Mutation of the <i>Csf1r</i> LocusClare Pridans, Anna Raper, Gemma M Davis, et al.
Lancet (London, England)|July 10, 2022
Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trialPeter J Mitchell, Bernard Yan, Leonid Churilov, et al.
Chemmedchem|March 12, 2015
P2-quinazolinones and bis-macrocycles as new templates for next-generation hepatitis C virus NS3/4a protease inhibitors: discovery of MK-2748 and MK-6325Michael T Rudd, John W Butcher, Kevin T Nguyen, et al.
Pageof 48